All In Biotech

Drug Trial Radar · NCT07459647

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

An Open-Label Study to Assess the Long-Term Safety, Tolerability, and Effectiveness of ML-007C-MA in Adult Participants With Schizophrenia

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Mar 31, 2026

Primary completion

Feb 2030

Study completion Feb 2030

Sponsor

Lead sponsor
MapLight TherapeuticsIndustry
Sponsor type
Industry
First posted
Mar 10, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

ML-007C-MA-212 is a 52-week open-label study designed to evaluate the long-term safety, tolerability, and effectiveness of ML-007C-MA in participants with schizophrenia who have recently completed an antecedent study (ML-007C-MA-211) or enroll directly (De Novo Cohort).

Conditions

  • Schizophrenia

Interventions

  • ML-007C-MADrug

    ML-007C-MA dosed as 210/3 mg BID

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the safety and tolerability of long-term ML-007C-MA administration in adult participants with schizophreniaTime frame: From initial dose through end of treatment (up to 52 weeks)

Locations

45 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Site

    Little Rock, Arkansas · Recruiting

  • Clinical Site

    Little Rock, Arkansas · Recruiting

  • Clinical Site

    Rogers, Arkansas · Recruiting

  • Clinical Site

    Bellflower, California · Recruiting

  • Clinical Site

    Cerritos, California · Recruiting

  • Clinical Site

    Culver City, California · Recruiting

  • Clinical Site

    Garden Grove, California · Recruiting

  • Clinical Site

    Lemon Grove, California · Recruiting

  • Clinical Site

    Long Beach, California · Recruiting

  • Clinical Site

    Los Angeles, California · Recruiting

  • Clinical Site

    Montclair, California · Recruiting

  • Clinical Site

    Oceanside, California · Recruiting

  • Clinical Site

    Orange, California · Recruiting

  • Clinical Site

    Pico Rivera, California · Recruiting

  • Clinical Site

    Riverside, California · Recruiting

  • Clinical Site

    San Diego, California · Recruiting

  • Clinical Site

    Sherman Oaks, California · Recruiting

  • Clinical Site

    Torrance, California · Recruiting

  • Clinical Site

    Hollywood, Florida · Recruiting

  • Clinical Site

    Hollywood, Florida · Recruiting

  • Clinical Site

    Miami, Florida · Recruiting

  • Clinical Site

    Miami, Florida · Recruiting

  • Clinical Site

    Miami Lakes, Florida · Recruiting

  • Clinical Site

    West Palm Beach, Florida · Recruiting

  • Clinical Site

    Atlanta, Georgia · Recruiting

  • Clinical Site

    Decatur, Georgia · Recruiting

  • Clinical Site

    Chicago, Illinois · Recruiting

  • Clinical Site

    Gaithersburg, Maryland · Recruiting

  • Clinical Site

    Boston, Massachusetts · Recruiting

  • Clinical Site

    Watertown, Massachusetts · Recruiting

  • Clinical Site

    Ann Arbor, Michigan · Recruiting

  • Clinical Site

    Flowood, Mississippi · Recruiting

  • Clinical Site

    Las Vegas, Nevada · Recruiting

  • Clinical Site

    Marlton, New Jersey · Recruiting

  • Clinical Site

    Cedarhurst, New York · Recruiting

  • Clinical Site

    New York, New York · Recruiting

  • Clinical Site

    Staten Island, New York · Recruiting

  • Clinical Site

    The Bronx, New York · Recruiting

  • Clinical Site

    North Canton, Ohio · Recruiting

  • Clinical Site

    West Chester, Ohio · Recruiting

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.